gallium nitrate has been researched along with Carcinoma 256, Walker in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clagett-Carr, K; Foster, BJ; Hoth, D; Leyland-Jones, B | 1 |
1 review(s) available for gallium nitrate and Carcinoma 256, Walker
| Article | Year |
|---|---|
Gallium nitrate: the second metal with clinical activity.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Gallium; Humans; Hypocalcemia; Kidney Diseases; Kinetics; Lymphoma; Tissue Distribution | 1986 |
1 trial(s) available for gallium nitrate and Carcinoma 256, Walker
| Article | Year |
|---|---|
Gallium nitrate: the second metal with clinical activity.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Gallium; Humans; Hypocalcemia; Kidney Diseases; Kinetics; Lymphoma; Tissue Distribution | 1986 |